Hanania et al. evaluated FeNO, serum periostin and blood eosinophilia as potential biomarkers useful to evaluate effectiveness of anti-IgE treatment on 850 adult persistent SA patients. The gene discussed is POSTN; the disease is Increased total eosinophil count.